mirror of
https://github.com/msberends/AMR.git
synced 2026-11-16 05:00:50 +01:00
(v3.1.0.9010) Fix the systematic underestimation of WISCA coverage by only including pathogens that occur in a group and were tested for the regimen, and warn when the prior weight of rare pathogens is large (fixes #337)
This commit is contained in:
1 parent
92bb8931c5
commit
fdfdadae14
6 files changed
+93
-13
No files matched your search
@@ -268,6 +268,10 @@ It does so by combining two quantities: the relative incidence of each pathogen
|
||||
|
||||
\strong{Prior distributions:} Pathogen incidence uses a non-informative \eqn{Dirichlet(1, 1, \ldots, 1)} prior. Susceptibility proportions use the Jeffreys prior, \eqn{\beta(0.5, 0.5)}, except for pathogen-drug combinations with known intrinsic resistance, which use a strongly informative \eqn{\beta(1, 9999)} prior that forces near-zero susceptibility regardless of observed data. Intrinsic resistance is determined using the \link{intrinsic_resistant} data set, which is based on \href{https://www.eucast.org/bacteria/important-additional-information/expert-rules/}{'EUCAST Expected Resistant Phenotypes' v1.2} (2023).
|
||||
|
||||
\strong{Pathogens included in the model:} For each regimen (and group), only pathogens that occur in the data and have at least one test result for the regimen are included. Pathogens without any test result for a regimen do not contribute to its coverage, nor to its \code{n_total} in \code{long_numeric}. Use \code{\link[=retrieve_wisca_parameters]{retrieve_wisca_parameters()}} to get the parameters that were used.
|
||||
|
||||
\strong{Rare pathogens:} Since every pathogen receives a prior weight of 1 in the Dirichlet distribution, pathogens found only once or a few times are given relatively much weight, which pulls the incidence towards a uniform distribution. Their very uncertain susceptibility can then strongly lower the estimated coverage, without reflecting the clinical expectation. A warning is therefore given when this prior weight accounts for more than 5\% of the pathogen incidence in any regimen (or group). Consider limiting the analysis to the most common pathogens using \code{\link[=top_n_microorganisms]{top_n_microorganisms()}}, or grouping rare pathogens before running WISCA.
|
||||
|
||||
\strong{Interpreting the output:} Overlapping credible intervals between regimens indicate no significant difference in coverage; if a narrower-spectrum regimen overlaps with a broader one, the narrower-spectrum option may be preferred on stewardship grounds. Non-overlapping intervals indicate a clinically meaningful difference. For small sample sizes, consider pooling data from multiple sites to improve precision, provided pathogen distributions are sufficiently similar (Bielicki \emph{et al.}, 2016).
|
||||
|
||||
For the full mathematical derivation and worked examples, see the \href{https://amr-for-r.org/articles/WISCA.html}{WISCA vignette}.
|
||||
|
||||
Reference in new issue
Block a user